Table 5.

Analysis of covariance (ANCOVA) for change from baseline for weeks 6 and 12 in SF-12v2: mental component score among seropositive patients (positive values denote improvement).

	Week 6				Week 12
Treatment Group	LS-Mean	SE	95% CI	P value	LS-Mean	SE	95% CI	P value
Placebo (PBO)	0.8	2.3	(−3.8, 5.4)		8.2	2.1	(3.9, 12.4)
600 - PBO	13.0	3.8	(5.6, 20.4)	<0.001	6.8	3.5	(−0.0, 13.6)	0.051
900 - PBO	7.9	5.0	(−2.0, 17.8)	0.117	6.2	4.7	(−3.0, 15.4)	0.184
(600+900) - PBO	10.4	3.5	(3.5, 17.4)	0.004	6.5	3.3	(0.1, 13.0)	0.048